comparemela.com

Latest Breaking News On - Company or mindmed - Page 9 : comparemela.com

MindMed to Host Investor Day June 2023

Mind Medicine Inc , , a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that its management team will a host an. | June 7, 2023

Medicine mindmed incCompany or mindmedMind medicineAnalyst dayNew york cityVirtual registrationInvestor resourcesMind medicine mindmed stock exchangePress releaseOst mnmd ca60255c8850

Mind Medicine: MindMed to Host Investor Day June 2023

Mind Medicine (MindMed) Inc (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders

Mecklenburg vorpommernMaxim jacobsStefan klotterMedicine mindmed incCompany or mindmedCorporate communicationsMind medicineAnalyst dayNew york cityVirtual registration linkInvestor resourcesMedia investor inquiriesInvestor relationsStabile ertrChart profi stefan klotterBlue chips

Leading Proxy Advisory Firm ISS Recommends MindMed Shareholders Vote FOR All Six Company Nominees

ISS Believes Company’s Director Nominees Represent an “Unusually Strong” Group of Current and Former Executives From Relevant Fields and Are Best Suited to Continue Overseeing. | June 5, 2023

New yorkUnited statesMatthias liechtiRobert barrowMedicine mindmed incMorrow sodaliCompany annual report on formCompany or mindmedUniversity hospital baselInstitutional shareholder services incCompany quarterly report on formCompany boardGreenleaf healthExchange commissionMind medicineInstitutional shareholder services

Mind Medicine: MindMed to Participate at Upcoming Investor Conferences

Mind Medicine (MindMed) Inc (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders

Maxim jacobsInternational conventionCompany or mindmedMedicine mindmed incCorporate communicationsMind medicineInvestor presentationHealthcare conferenceJefferies healthcare conferenceInvestor resourcesMedia investor inquiriesInvestor relations

MindMed to Participate at Upcoming Investor Conferences

Mind Medicine Inc , , a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that members of the Company’s management. | June 1, 2023

Company or mindmedMedicine mindmed incInternational conventionMind medicineInvestor presentationJefferies healthcareInvestor resourcesMind medicine mindmed stock exchangePress releaseHe mnmd ca60255c8850

vimarsana © 2020. All Rights Reserved.